heart disease

R&D

Cardiovascular disease today: NMR-based lipoprotein profilin...

pharmaphorum spoke with Andreas Wolf, chief technology officer at numares Health about NMR-based lipoprotein profiling and cardiovascular disease.

Digital

The role of NHS Big Data and AI technology in unlocking the ...

The UK stands at the cusp of a new era of medical breakthroughs, fuelled by the increased use of data and the recent plans to open NHS data reserves to improve the development and creation

Digital

ECG data and AI will fuel pharma’s next drug development and...

Discover how the integration of ECG data and AI is transforming the pharmaceutical industry, revolutionising drug development and commercialisation.

R&D

Modernising clinical trials: The PARTICIPATE framework

Each year, a staggering 67 million individuals lose their lives.1 Heart disease account for approximately 17.9 million of these deaths,2 and cancer takes away 10 milli

R&D

Health Innovators – Fady Malik and Steve Heitner

In this instalment of Health Innovators, EiC Jonah Comstock sits down virtually with Fady Malik, EVP of research and development at Cytokinetics and Steve Heitner, the company’s VP of clinical rese

News